Awarded Contractocds-tedeu-91cdb530-803b-4b94-ab41-a582a46b8fba
Infliximab
Le marché concerne les fournitures de la spécialité pharmaceutique contenant le principe actif « Infliximab ».
Buyer
Cliniques universitaires Saint Luc
Value
€2,492,000
Published
18 Aug 2026
Closes
Not provided
Procurement details
Source
TED (EU)
Country
Belgium (BE)
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33652000
Antineoplastic and immunomodulating agents
Lots
Lot LOT-0001 PHARM-2025-817 - 1
€2,492,000
Infliximab
Delivery: BE100 · Belgium, BE310 · Belgium
Documents
Unlock document linkTED notice 573716-2026
18 Aug 2026
Award notice · Web page
Contains information from TED (Tenders Electronic Daily), © European Union, reused under CC BY 4.0.